trimbow 87microgramsdose 5microgramsdose 9microgramsdose inhaler
chiesi ltd - beclometasone dipropionate; glycopyrronium bromide; formoterol fumarate dihydrate - pressurised inhalation - 87microgram/1dose ; 9microgram/1dose ; 5microgram/1dose
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrate, glycopyrronium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.1).asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
trydonis
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrate, glycopyrronium - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist (for effects on symptoms control and prevention of exacerbations see section 5.1).
trimbow pressurised inhalation solution 100612.5 μg per actuation
orient europharma pte ltd - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate; glycopyrronium bromide - aerosol, metered - beclometasone dipropionate anhydrous 0.1mg/actuation; formoterol fumarate dihydrate 0.006mg/actuation; glycopyrronium bromide 0.0125mg/actuation
foster 1006 mcgdose pressurised inhalation solution
orient europharma (m) sdn bhd - beclometasone dipropionate; formoterol fumarate dihydrate -
inuvair 200 µg/dose - 6 µg/dose press. inhal. sol. multidos. cont.
chiesi sa-nv - beclometasone dipropionate 200 µg/dose; formoterol fumarate dihydrate 6 µg/dose - pressurised inhalation, solution - 200 µg/dose - 6 µg/dose - beclometasone dipropionate 200 µg/dose; formoterol fumarate dihydrate 6 µg/dose - formoterol and beclometasone
inuvair nexthaler 100 µg/dose - 6 µg/dose inhal. pwdr. inhaler
chiesi sa-nv - beclometasone dipropionate 100 µg/dose; formoterol fumarate dihydrate 6 µg/dose - inhalation powder - 100 µg/dose - 6 µg/dose - beclometasone dipropionate 100 µg/dose; formoterol fumarate dihydrate 6 µg/dose - formoterol and beclometasone
formoterol easyhaler 12microgramsdose dry powder inhaler
orion pharma (uk - formoterol fumarate dihydrate - inhalation powder - 12microgram/1dose
novolizer formoterol 6 micrograms/dose inhalation powder
mylan ire healthcare limited - formoterol fumatrate dihydrate - powder for inhalation - 6 microgram(s) - selective beta-2-adrenoreceptor agonists; formoterol
fostair nexthaler 100/6
chiesi gmbh - dipropionate anhydrous, formoterol fumarate dihydrate. - inhalation powder. - 200 micrograms/6 micrograms for metered dose - rugs for obstructive airway diseases; adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics. - fostair nexthaler is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonist or - patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists. fostair nexthaler is indicated in adults. note: there are no relevant clinical data on the use of fostair nexthaler for the treatment of acute asthma attacks.